Related references
Note: Only part of the references are listed.Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma
Alessia Guarneri et al.
WORLD JOURNAL OF UROLOGY (2013)
PSA Nadir of <0.5 ng/mL Following Brachytherapy for Early-Stage Prostate Adenocarcinoma is Associated With Freedom From Prostate-Specific Antigen Failure
Eric C. Ko et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Results of a Surgically Derived Nomogram to Predict Gleason Score Upgrading Applied to a Cohort of Patients With Favorable-risk Prostate Cancer Treated With Permanent Seed Brachytherapy
David Bowes et al.
UROLOGY (2012)
FIFTEEN-YEAR BIOCHEMICAL RELAPSE-FREE SURVIVAL, CAUSE-SPECIFIC SURVIVAL, AND OVERALL SURVIVAL FOLLOWING I125 PROSTATE BRACHYTHERAPY IN CLINICALLY LOCALIZED PROSTATE CANCER: SEATTLE EXPERIENCE
John E. Sylvester et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
LONG-TERM OUTCOME FOR CLINICALLY LOCALIZED PROSTATE CANCER TREATED WITH PERMANENT INTERSTITIAL BRACHYTHERAPY
Al V. Taira et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
NATURAL HISTORY OF CLINICALLY STAGED LOW- AND INTERMEDIATE-RISK PROSTATE CANCER TREATED WITH MONOTHERAPEUTIC PERMANENT INTERSTITIAL BRACHYTHERAPY
Al V. Taira et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
YOUNG MEN HAVE EQUIVALENT BIOCHEMICAL OUTCOMES COMPARED WITH OLDER MEN AFTER TREATMENT WITH BRACHYTHERAPY FOR PROSTATE CANCER
Ryan J. Burri et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
The second decade of prostate brachytherapy: Evidence and cost based outcomes
Philip Vigneri et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Long-Term Outcomes in Younger Men Following Permanent Prostate Brachytherapy
Edan Y. Shapiro et al.
JOURNAL OF UROLOGY (2009)
Biochemical and Functional Outcomes Following Brachytherapy With or Without Supplemental Therapies in Men ≤50 Years of Age With Clinically Organ-Confined Prostate Cancer
Gregory S. Merrick et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Distant and local recurrence in patients with biochemical failure after prostate brachytherapy
Richard G. Stock et al.
BRACHYTHERAPY (2008)
Second primary cancer after radiotherapy for prostate cancer - A SEER analysis of brachytherapy versus external beam radiotherapy
May Abdel-Wahab et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer (Reprinted from The Journal of Urology, vol 173, pg 1562-1566, 2005)
Louis Potters et al.
JOURNAL OF UROLOGY (2008)
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103
Mark J. Rivard et al.
BRACHYTHERAPY (2007)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Disease-specific survival following the brachytherapy management of prostate cancer
RG Stock et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer
NN Stone et al.
JOURNAL OF UROLOGY (2005)
Rectal function following prostate brachytherapy
GS Merrick et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
